UAB "GL Pharma Vilnius" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
917,054 |
152,842 |
43,425 |
35,237 |
5,873 |
41.48 |
3.84 |
189,265 |
75,736 |
6,449 |
257,831 |
2022 |
---|
1,004,910 |
167,485 |
48,053 |
38,756 |
6,459 |
100.00 |
3.86 |
228,021 |
57,406 |
4,875 |
279,769 |
2023 |
---|
1,101,340 |
183,557 |
16,822 |
10,947 |
1,825 |
100.00 |
0.99 |
238,968 |
84,054 |
5,341 |
325,685 |
Register and
explore Okredo data2023 |
---|
1,101,340 |
183,557 |
16,822 |
10,947 |
1,825 |
100.00 |
0.99 |
238,968 |
84,054 |
5,341 |
325,685 |
Register and
explore Okredo data2023
Turnover (€)
1,101,340 €10 % *
Sales per employee (€)
183,557 €10 % *
Profit before tax (€)
16,822 €-65 % *
Net Profit (€)
10,947 €-72 % *
Profit per employee (€)
1,825 €-72 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
0.99 %-74.35 % *
Equity (€)
238,968 €5 % *
Amounts Payable And Liabilities (€)
84,054 €46 % *
Non-current Assets (€)
5,341 €10 % *
CurrentAssets (€)
325,685 €16 % *